38 filings
8-K
SRZN
Surrozen Inc
8 May 24
Surrozen Provides First Quarter 2024 Financial Results and Business Update
4:12pm
8-K
SRZN
Surrozen Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:07pm
8-K
SRZN
Surrozen Inc
1 Apr 24
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
8:52am
8-K
SRZN
Surrozen Inc
7 Feb 24
Departure of Directors or Certain Officers
6:10am
8-K
SRZN
Surrozen Inc
18 Jan 24
Other Events
8:41am
8-K
qnxhd72zon 4d2
13 Dec 23
Amendments to Articles of Incorporation or Bylaws
5:14pm
8-K
ztopqkyl4gohj
11 Dec 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
lvv5iiq
8 Nov 23
Surrozen Provides Third Quarter 2023 Financial Results
4:09pm
8-K
v8r221jr
13 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:19pm
8-K
1khgdvmnhkzq
9 Aug 23
Surrozen Provides Second Quarter 2023 Financial Results
4:16pm
8-K
uov3k80ug 3g
19 Jul 23
Departure of Directors or Certain Officers
4:15pm
8-K
opnogz 3d9xh
5 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
8gkgrmvju14vn9w8zhp9
22 May 23
Submission of Matters to a Vote of Security Holders
1:45pm
8-K
wpnl8176s
10 May 23
Surrozen Provides First Quarter 2023 Financial Results and Corporate and Pipeline Updates
4:14pm
8-K
v6g4v9a10l6c
5 Apr 23
Departure of Directors or Certain Officers
4:19pm
8-K
idvkco 752p
23 Mar 23
Other Events
8:01am
8-K
n99fgh kvq
22 Mar 23
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress
4:30pm
8-K
evb osmg5q29ra
5 Jan 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:32pm
8-K
4xk2088ty d0z
15 Dec 22
Other Events
9:21am
8-K
ob73rzu 2mc43rlh
15 Nov 22
Surrozen Reports Third Quarter 2022 Financial Results and Provides Corporate Update
8:12pm